Integer Holdings Corporation
Moat Score — Integer Holdings Corporation
Total Moat Score
16 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 4 / 5 | Integer holds 731 owned patents and decades of FDA-regulated process know-how across its Greatbatch Medical and Lake Region Medical legacy brands, covering highly technical areas like implantable batteries, feedthroughs, and catheter manufacturing that are difficult to replicate quickly. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 3 / 5 | As one of the largest medical device CDMOs by capability breadth, Integer has scale advantages in regulated manufacturing, but the CDMO industry remains fragmented with hundreds of competitors, so it is not a dominant low-cost provider. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Severe customer concentration caps pricing power: Abbott, Boston Scientific, and Medtronic together are 49% of 2025 sales, and large OEMs deliberately dual-source to avoid depending on Integer's pricing terms. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Contract manufacturing of medical device components has no network effect; the value Integer delivers to one OEM customer does not increase because other OEMs also use Integer. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 4 / 5 | Once a component like a battery, feedthrough, or catheter is designed into an OEM's FDA-cleared device, switching suppliers requires costly and lengthy regulatory requalification, which is Integer's strongest and most durable moat source. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | Integer's breadth across both components and finished devices is matched by few competitors, but the overall CDMO market has hundreds of participants, so the efficient-scale advantage is real but not a hard barrier to new or expanding entrants. |